Autologous Skin Substitute for Chronic Leg/Foot Ulcers.
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
A prospective, multicenter, randomised controlled phase II study in which patients with
therapy resistant (arterio-) venous leg/foot ulcers are treated with Tiscover® (test group)
or with AS210 (control group) to determine the safety and relative efficacy of both products.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chantal Blok
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development